Breathing life into BMY's reject

York Medical Inc. is going to get a chance to see if it has better instincts than Bristol-Meyers Squibb Corp. York has acquired from the University of Manitoba and CancerCare Manitoba exclusive rights to a small molecule chemopotentiator,

Read the full 384 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE